Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers

Gian Luca Salvagno^1,2, Brandon M. Henry^3,4, Laura Pighi^1,2, Simone De Nitto^1,2, Gianluca Gianfilippi⁵, Giuseppe Lippi^1
1Section of Clinical Biochemistry, University of Verona, Verona, Italy
²Service of Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy
³Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
⁴Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio,Texas, USA
⁵Medical Direction, Pederzoli Hospital, Peschiera del Garda, Italy